ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "race/ethnicity"

  • Abstract Number: 0673 • ACR Convergence 2023

    Reporting of Race, Ethnicity, Sex, Gender, Socioeconomic Status and Representativeness of Race and Ethnicity in ANCA-associated Vasculitis Randomized Trials

    Michele Iudici1, Juan C. Rueda2 and Xavier Puéchal3, 1Division of Rheumatology, Department of Internal Medicine Specialties, Geneva University Hospitals, Geneva, Switzerland, 2Universidad de La Sabana, Chía, Colombia, Chia, Colombia, 3National Referral Center for Rare Systemic Autoimmune Diseases, Paris, France

    Background/Purpose: To assess how and to what extent race, ethnicity, sex, gender and socioeconomic status of participants are reported in ANCA-associated vasculitis (AAV) randomized controlled…
  • Abstract Number: 1562 • ACR Convergence 2023

    Behcet’s Disease Coagulopathy in a Racially Diverse Patient Population

    Sundus Mian1, Talia Meisel2, Hussain Md1, Xianhong Xie3, Tamara Tanner1, Anand Kumthekar4 and Bibi Ayesha4, 1Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, 2Montefiore Medical Center, Bronx, NY, 3Albert Einstein College of Medicine, Bronx, NY, 4Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY

    Background/Purpose: Behcet's disease (BD) is a vasculitis with both thrombotic and bleeding complications which can make management challenging. Thrombosis is due to direct vascular inflammation,…
  • Abstract Number: 0711 • ACR Convergence 2023

    IgA Vasculitis in a Diverse Adult Patient Population

    Michelle Toker1, Urmi Khanna1, Roya Nazarian1, Adhya Mehta2, Bibi Ayesha1, Anand Kumthekar1 and Benedict Wu1, 1Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, 2Jacobi Medical Center, Bronx, NY

    Background/Purpose: Immunoglobulin-A (IgA) Vasculitis (IgAV) is a small-vessel vasculitis that is primarily diagnosed based on the European League Against Rheumatism (EULAR) criteria. There is limited…
  • Abstract Number: 1624 • ACR Convergence 2023

    Racial Disparities Impact Achieving LLDAS and Glucocorticoid Use in Pediatric Lupus: A CARRA Registry Study

    William Soulsby1, Rebecca Olveda1, Jie He2, Laura Berbert2, Edie Weller2, Kamil Barbour3, Kurt Greenlund3, Laura Schanberg4, Emily von scheven1, Aimee Hersh5, Mary Beth Son6, Joyce Chang2 and Andrea Knight7, 1University of California San Francisco, San Francisco, CA, 2Boston Children's Hospital, Boston, MA, 3Centers for Disease Control and Prevention, Atlanta, GA, 4Duke University School of Medicine, Durham, NC, 5University of Utah, Salt Lake City, UT, 6Division of Immunology, Boston Children's Hospital, Boston, MA, 7The Hospital for Sick Children, Toronto, ON, Canada

    Background/Purpose: Social determinants of health (SDoH) contribute to disparate outcomes in both adult and pediatric systemic lupus erythematosus (pSLE), including length of hospitalization, mortality, and…
  • Abstract Number: 0753 • ACR Convergence 2023

    Facility Variation in HLA-B*58:01 Allele Testing for Asian and Black Patients Receiving Allopurinol in the Veterans Affairs Healthcare System

    Jeremy Sullivan1, Anna Ware2, Gary Tarasovsky3, Cherish Wilson4, Mary Whooley3, Jasvinder Singh5, Jinoos Yazdany6 and Gabriela Schmajuk4, 1University of California San Francisco, San Francisco, CA, 2Palo Alto VA, Minneapolis, MN, 3San Francisco VA, San Francisco, CA, 4UCSF / SFVA, San Francisco, CA, 5University of Alabama at Birmingham, Birmingham, AL, 6University of California, General Department of Medicine, Division of Rheumatology, San Francisco, CA

    Background/Purpose: New guidelines published in 2020 conditionally recommend HLA-B*58:01 allele testing for South Asian and Black patients receiving allopurinol to reduce the risk of severe…
  • Abstract Number: 1639 • ACR Convergence 2023

    PsA Patients of Diverse Ethnic and Racial Backgrounds Experience More Skin Psoriasis, Increased Pain, and Higher Rates of Radiographic Axial Disease

    Rebecca Haberman1, Tasneem Ahmed2, Seungha Um1, Ying Yin Zhou1, Sydney Catron1, Kathryn Jano1, Sarah Moussavi1, Eileen Lydon2, Alexandra Rice1, Andrea Neimann1, Soumya Reddy3, Samrachana Adhikari1 and Jose Scher4, 1NYU Grossman School of Medicine, New York, NY, 2New York University, New York, NY, 3NYU School of Medicine, New York, NY, 4New York University School of Medicine, New York, NY

    Background/Purpose: Individuals of diverse ethnic and racial backgrounds are generally underrepresented in psoriatic arthritis (PsA) research and clinical trials, despite evidence that their disease presentation,…
  • Abstract Number: 0809 • ACR Convergence 2023

    Underserved by Rehabilitation: Characteristics Among Adults with Rheumatoid Arthritis

    Chris Lane1, Lauren Mihalek2, Kelli Allen3, Beth Jonas4, Patti Katz5 and Louise Thoma6, 1UNC Chapel Hill, Chapel Hill, NC, 2University of North Carolina - Chapel Hill, Chapel Hill, NC, 3University of North Carolina, Durham, NC, 4University of North Carolina at Chapel Hill, Chapel Hill, NC, 5University of California San Francisco, San Rafael, CA, 6University of North Carolina, Chapel Hill, NC

    Background/Purpose: Adults with rheumatoid arthritis (RA) often experience functional limitations (e.g., difficulty walking, dressing oneself), even with low disease activity and good pharmaceutical management. Rehabilitation…
  • Abstract Number: 1652 • ACR Convergence 2023

    Lupus Research Action Network: Increasing Minority Clinical Trial Participation Through Peer Leaders

    Melicent Miller1, Stephanie Slan1, Rosalind Ramsey-Goldman2, Rodlescia Sneed3, Candace Feldman4, Patrick Wildman1, Tori Justin5, Lydia Oberholtzer5 and Joy Buie6, 1Lupus Foundation of America, Washington, DC, 2Northwestern University, Chicago, IL, 3Wayne State University, Detroit, MI, 4Brigham and Women's Hospital, Boston, MA, 5Sharp Insight, LLC, Montgomery County, MD, 6Lupus Foundation of America, York, SC

    Background/Purpose: Black/African American people with lupus (PWL) experience greater disease prevalence and severity than White PWL. The need for more racial and ethnic diversity amongst…
  • Abstract Number: 0994 • ACR Convergence 2023

    Narrative Medicine and Pediatric Rheumatology: Addressing Burnout and Bias

    Aviya Lanis, Natalie Rosenwasser and Esi Morgan, Seattle Children's Hospital, Seattle, WA

    Background/Purpose: Burnout, a syndrome of emotional exhaustion and depersonalization, adversely impacts healthcare and results in mood disturbances, poor patient and provider satisfaction and high turnover.…
  • Abstract Number: 1947 • ACR Convergence 2023

    National Incidence, Prevalence & Mortality in Idiopathic Inflammatory Myopathies & Associated Interstitial Lung Disease in England

    Jennifer Hannah1, Fiona Pearce2, Myron Odingo2, Megan Rutter2, Jeanette Aston3, Jennifer Lai3, Matthew Grainge2, Sean Mcphail3, Peter Lanyon2, Mary Bythell3, James Galloway4 and Patrick Gordon5, 1King's College London, London, United Kingdom, 2University of Nottingham, Nottingham, United Kingdom, 3National Disease Registration Service, Leeds, United Kingdom, 4King's College London, London, United Kingdom, 5NHS, London, United Kingdom

    Background/Purpose: Ethnicity, sex, age & socioeconomic deprivation can all lead to health inequity. Impact of these factors in epidemiology of Idiopathic Inflammatory Myopathies (IIM) has…
  • Abstract Number: 101 • 2023 Pediatric Rheumatology Symposium

    Differences in Clinical and Patient-reported Outcomes in Juvenile Dermatomyositis by Race and Ethnicity

    Susan Kim1, Rebecca Olveda2 and Jessica Neely2, 1UCSF Benioff Children's Hospital, San Francisco, CA, 2UCSF, San Francisco, CA

    Background/Purpose: Previous studies in juvenile dermatomyositis (JDM) have shown that patients from minoritized ethnicities and those with lower family income are more likely to have…
  • Abstract Number: 137 • 2023 Pediatric Rheumatology Symposium

    Geographic Mapping of Adolescents with Rheumatic Disease: Racial and Ethnic Diversity by Texas County

    Kristina Ciaglia1, Chan-hee Jo2, Yuhan Ma2, Tracey Wright3 and Lorien Nassi1, 1University of Texas Southwestern, Dallas, TX, 2Scottish Rite Hospital for Children, Dallas, TX, 3University of Texas Southwestern, Scottish Rite Hospital for Children, Dallas, TX

    Background/Purpose: Rheumatic disease disproportionately impacts specific racial and ethnic groups frequently, resulting in health care inequities. Health care disparities are prevalent within certain geographic areas…
  • Abstract Number: 003 • 2023 Pediatric Rheumatology Symposium

    Inflammation or Infection? Understanding Linguistic and Cultural Nuances Impacting the Care of Somali Children with Juvenile Idiopathic Arthritis

    Emily Hause, Abdirazak Ali and Muna Sunni, University of Minnesota, Minneapolis, MN

    Background/Purpose: Data regarding the linguistic and cultural factors impacting the Somali patient experience and understanding with regards to juvenile idiopathic arthritis (JIA) are limited. We…
  • Abstract Number: 022 • 2023 Pediatric Rheumatology Symposium

    Narrative Medicine and Pediatric Rheumatology: Addressing Burnout and Bias

    aviya lanis, Natalie Rosenwasser and Esi Morgan, Seattle Children's Hospital, Seattle, WA

    Background/Purpose: Burnout, a syndrome of emotional exhaustion and depersonalization, adversely impacts healthcare. This can result in mood disturbances, poor patient and provider satisfaction and high…
  • Abstract Number: 0131 • ACR Convergence 2022

    Racial Differences in Bone Health of Sarcoidosis Patients: A Retrospective Study

    Emily Peninger1, Christian Ascoli2, Rachel Lane2, Subash Kukreja2, Robert Baughman3 and Nadera Sweiss2, 1University of Chicago, Chicago, IL, 2University of Illinois at Chicago, Chicago, IL, 3University of Cincinnati, Cincinnati, OH

    Background/Purpose: Bone health in sarcoidosis is a complex topic, though data regarding racial differences in this population is lacking. Our study sought to identify racial…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 16
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology